Contrary to an earlier epidemiological study, rosiglitazone use is not associated with an increased risk of developing cancer, according to a new report.
Read More »Diabetes In Control
Circulator Boot™ Long-Boot, Valve Assembly and Heart Monitor
Long-Boot, Valve Assembly and Heart Monitor Many people with diabetes are at risk of developing wounds on their feet that just won’t heal
Read More »Tool for Your Practice: Simple Demonstration
Tina Trout can talk to patients about the way uncontrolled diabetes can affect their bodies, from heart disease to blindness and kidney problems, but sometimes it’s the visual demonstration that works best. She shows them two jars, each filled with a red liquid. One represents the blood of healthy people; …
Read More »Neurophysiological Pathways to Obesity Below Awareness and Beyond Individual Control
Our new intern, Kate Messamore, PharmD Candidate, University of Florida has reviewed Neurophysiological Pathways to Obesity: Below Awareness and Beyond Individual Control written by Deborah A. Cohen, MD, MPH, at the RAND Corporation. This is some unbelievable information you have to read.
Read More »Exercise Pill Offers Fitness Without Effort
Is this the magic pill we have all been waiting for? Can you enjoy the benefits of exercise without the pain of exertion? Forget treadmills and spin classes? The answer may one day be yes — just take a pill that tricks the muscles into thinking they have been working …
Read More »Women With Diabetes Prior to Pregnancy Linked With Birth Defects
Women diagnosed with diabetes before their pregnancy have a higher risk of giving birth to a baby with a birth defect or multiple defects than a woman who does not have diabetes before giving birth, according to a new study. “For single [birth] defects, the risk is three to four times …
Read More »Possible New Diabetes Drug Succinobucol Meets Main Goal
AtheroGenics, Inc, a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today announced top-line results from its ANDES Phase 3 clinical trial of AGI-1067 (succinobucol) for the treatment of Type 2 diabetes demonstrating that both doses (75mg and 150mg) of AGI-1067 met the primary efficacy endpoint of the …
Read More »Adiponectin May Increase Risk of Heart Attack
Adiponectin, a protein produced by fat cells, may play a pivotal and counterintuitive role in cardiovascular health for older Americans according to a new study.
Read More »Artificial Pancreas Getting Close
Researchers working on an artificial pancreas believe they are just a few years away from a nearly carefree way for people with diabetes to monitor blood and inject insulin as needed.
Read More »Worrying Increases Men’s Diabetes Risk But Not For Women
Anxiety, depression and sleepless nights increase the risk of diabetes in men, a Swedish study suggests. Researchers found men with high levels of “psychological distress” had more than double the risk of developing type 2 diabetes than those with low levels.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.